MediWound, which is developing treatments for severe burns and other hard-to-heal wounds, raised $70 million by offering 5.0 million shares at $14, the low end of the $14 to $16 range. MediWound plans to list on the NASDAQ under the symbol MDWD. Credit Suisse, Jefferies and BMO Capital Markets acted as joint bookrunners on the deal.
